| Inhaled nanoparticles—a current review W Yang, JI Peters, RO Williams III International journal of pharmaceutics 356 (1-2), 239-247, 2008 | 834 | 2008 |
| Influence of particle size on regional lung deposition–what evidence is there? TC Carvalho, JI Peters, RO Williams III International journal of pharmaceutics 406 (1-2), 1-10, 2011 | 655 | 2011 |
| Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs J Hu, KP Johnston, RO Williams III Drug development and industrial pharmacy 30 (3), 233-245, 2004 | 488 | 2004 |
| Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization ME Matteucci, MA Hotze, KP Johnston, RO Williams Langmuir 22 (21), 8951-8959, 2006 | 430 | 2006 |
| Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery–an update SV Jermain, C Brough, RO Williams III International journal of pharmaceutics 535 (1-2), 379-392, 2018 | 423 | 2018 |
| The COVID-19 vaccine race: challenges and opportunities in vaccine formulation J Wang, Y Peng, H Xu, Z Cui, RO Williams Aaps Pharmscitech 21, 1-12, 2020 | 379 | 2020 |
| Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery C Brough, RO Williams Iii International journal of pharmaceutics 453 (1), 157-166, 2013 | 340 | 2013 |
| Enhanced drug dissolution using evaporative precipitation into aqueous solution M Sarkari, J Brown, X Chen, S Swinnea, RO Williams III, KP Johnston International journal of pharmaceutics 243 (1-2), 17-31, 2002 | 270 | 2002 |
| Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution X Chen, TJ Young, M Sarkari, RO Williams III, KP Johnston International journal of pharmaceutics 242 (1-2), 3-14, 2002 | 262 | 2002 |
| Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole JC DiNunzio, DA Miller, W Yang, JW McGinity, RO Williams III Molecular pharmaceutics 5 (6), 968-980, 2008 | 223 | 2008 |
| Process for production of nanoparticles and microparticles by spray freezing into liquid RO Williams III, KP Johnston, TJ Young, TL Rogers, MK Barron, Z Yu, ... US Patent 6,862,890, 2005 | 214 | 2005 |
| A novel particle engineering technology: spray-freezing into liquid TL Rogers, J Hu, Z Yu, KP Johnston, RO Williams III International Journal of pharmaceutics 242 (1-2), 93-100, 2002 | 210 | 2002 |
| Formulating poorly water soluble drugs RO Williams III, AB Watts, DA Miller Springer, 2012 | 196 | 2012 |
| Topical compositions and methods for treating pain RO Williams, F Zhang US Patent 6,638,981, 2003 | 194 | 2003 |
| Solution-Based Particle Formation of Pharmaceutical Powders by Supercritical or Compressed Fluid Co2 and Cryogenic Spray-Freezing Technologies TL Rogers, KP Johnston, RO Williams III Drug development and industrial pharmacy 27 (10), 1003-1015, 2001 | 194 | 2001 |
| Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin RO Williams III, V Mahaguna, M Sriwongjanya European journal of pharmaceutics and biopharmaceutics 46 (3), 355-360, 1998 | 193 | 1998 |
| A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid TL Rogers, AC Nelsen, J Hu, JN Brown, M Sarkari, TJ Young, ... European journal of pharmaceutics and biopharmaceutics 54 (3), 271-280, 2002 | 190 | 2002 |
| Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersing JC DiNunzio, C Brough, JR Hughey, DA Miller, RO Williams III, ... European journal of pharmaceutics and biopharmaceutics 74 (2), 340-351, 2010 | 188 | 2010 |
| Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems J Hu, KP Johnston, RO Williams III European Journal of Pharmaceutical Sciences 20 (3), 295-303, 2003 | 188 | 2003 |
| Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition DA Miller, JC DiNunzio, W Yang, JW McGinity, RO Williams III Drug development and industrial pharmacy 34 (8), 890-902, 2008 | 181 | 2008 |
